A Personalized, 3-Dimensionally Printed, Oronasal Noninvasive Ventilation Mask for an Infant with Acute Respiratory Failure

Noninvasive ventilation (NIV) is a first-line treatment for acute respiratory failure in the intensive care unit (ICU), but interface selection poses a major challenge.1 Commercial masks are not well adapted to the wide variety of facial dimensions of young children, resulting frequently in large, unintended air leakage, skin-pressure injuries, patient-ventilator asynchrony, and discomfort.1 As such, mask fit is a potentially modifiable factor to increase NIV treatment success in pediatric acute respiratory failure, underscoring the need for personalized strategies.

Journal Article (2026)
Author(s)

Rosemijne R.W.P. Pigmans (Amsterdam Reproduction and Development, Amsterdam UMC)

Rozalinde Klein-Blommert (Amsterdam UMC)

Toon Huysmans (TU Delft - Industrial Design Engineering)

Coen D. Dijkman (Amsterdam UMC)

Reinout A. Bem (Amsterdam UMC, Amsterdam Reproduction and Development)

Research Group
Human Factors
DOI related publication
https://doi.org/10.1016/j.jpeds.2026.115059 Final published version
More Info
expand_more
Publication Year
2026
Language
English
Research Group
Human Factors
Journal title
Journal of Pediatrics
Volume number
293
Article number
115059
Downloads counter
31
Reuse Rights

Other than for strictly personal use, it is not permitted to download, forward or distribute the text or part of it, without the consent of the author(s) and/or copyright holder(s), unless the work is under an open content license such as Creative Commons.

Abstract

Noninvasive ventilation (NIV) is a first-line treatment for acute respiratory failure in the intensive care unit (ICU), but interface selection poses a major challenge.1 Commercial masks are not well adapted to the wide variety of facial dimensions of young children, resulting frequently in large, unintended air leakage, skin-pressure injuries, patient-ventilator asynchrony, and discomfort.1 As such, mask fit is a potentially modifiable factor to increase NIV treatment success in pediatric acute respiratory failure, underscoring the need for personalized strategies.